C2i Genomics vs Senseera
C2i Genomics vs Senseera, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: C2i Genomics is on 62/100 and Senseera on 54/100.
Where each one leads
C2i Genomics
- our overall score: 62/100 against 54/100
- agent readiness: 30/100 against 21/100
- domain rating: 63/100 against 18/100
- funding raised: $112M against $7.1M
- LinkedIn following: 6,366 against 1,579
Senseera
Leads on none of the measures we hold for both companies.
At a glance
| Measure | C2i Genomics | Senseera |
|---|---|---|
| What it is | Comprehensive whole-genome monitoring for cancer recurrence and progression. | Developing a liquid biopsy blood test for early disease detection and monitoring using epigenetic information. |
| Category | Healthcare, Genomics, Cancer, Tumor Detection | Healthcare, Blood, Diagnostics, Cancer |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2018 | 2020 |
| Headquarters | Tel Aviv, Israel | San Diego, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | C2i Genomics | Senseera |
|---|---|---|
| Employees | 17 | 20 |
| Headcount growthLast 12 months | -20.8% | Not published |
| Total funding | $112M | $7.1M |
| Latest round | Series B | Seed |
| LinkedIn followers | 6,366 | 1,579 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | C2i Genomics | Senseera |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 62/100 | 54/100 |
| Traction | 53/100 | 47/100 |
| Team | 90/100 | 60/100 |
| Search visibility | 35/100 | 34/100 |
| Quality | 65/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (30/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 63/100 | 18/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | C2i Genomics | Senseera |
|---|---|---|
| Hosting | Not detected | Self Managed |
| CDN | Cloudflare | Not detected |
| CMS | WordPress | WordPress |
| Frameworks | Jquery, Bootstrap | Jquery |
| Analytics | Google Analytics 4, Google Tag Manager | Not detected |
C2i Genomics vs Senseera: common questions
Which is better, C2i Genomics or Senseera?
On our 0-100 score C2i Genomics rates higher (62/100 against 54/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.
How do C2i Genomics and Senseera compare on the numbers?
C2i Genomics leads on our overall score (62/100 against 54/100), agent readiness (30/100 against 21/100), domain rating (63/100 against 18/100), funding raised ($112M against $7.1M), LinkedIn following (6,366 against 1,579).
Read the full C2i Genomics review and pricing or the Senseera review and pricing. You can also browse other C2i Genomics alternatives we track.

